Conclusion
The study confirms propranolol’s effectiveness and safety, reinforcing the need for early intervention and close monitoring following treatment termination to prevent regrowth. Ultimately, this research contributes to advancing the understanding and treatment of IH, aiming to optimize patient outcomes and reduce morbidity.
Key words: Infantile hemangioma, Vascular anomalies, Vascular malformation, Propranolol, B-blockers